A Phase 1, Single-Blind, Randomized, Placebo Controlled, Parallel-Group, Multiple-Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2018
At a glance
- Drugs Emodepside (Primary)
- Indications Filariasis
- Focus Adverse reactions; First in man
- 20 Jun 2018 Planned End Date changed from 2 Jul 2018 to 1 Oct 2018.
- 20 Jun 2018 Planned primary completion date changed from 2 Jul 2018 to 1 Oct 2018.
- 03 Jan 2018 New trial record